<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04761094</url>
  </required_header>
  <id_info>
    <org_study_id>C-386</org_study_id>
    <nct_id>NCT04761094</nct_id>
  </id_info>
  <brief_title>Clinical Efficacy of Insulin Pumps in Type 1 Diabetes Mellitus Patients in Spain</brief_title>
  <official_title>Clinical Efficacy of Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Mellitus Patients in Spain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Castilla-La Mancha Health Service</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spanish Diabetes Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Castilla-La Mancha Health Service</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational cross-sectional multicenter study about clinical efficacy of insulin pumps in&#xD;
      type 1 diabetes mellitus patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational cross-sectional multicenter study about clinical efficacy of continuous&#xD;
      subcutaneous insulin infusion in type 1 diabetes mellitus patients.&#xD;
&#xD;
      All clinical variables are gathered from the Spanish Insulin Pump National Registry.&#xD;
&#xD;
      Data analysis is conducted using SPSS (Chicago, IL) statistic software. Results are presented&#xD;
      as mean +/- SD values. A paired Student's t-test or a Wilcoxon signed-rank test were used for&#xD;
      the analysis of differences. Comparisons between proportions were analyzed using a&#xD;
      chi-squared test. A P value &lt; 0.05 was considered statistically significant.&#xD;
&#xD;
      The protocol was approved by the reference Castilla-La Mancha Public Health Institute Ethic&#xD;
      Committee. All participants provided written informed consent.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>9 Months</target_duration>
  <primary_outcome>
    <measure>HbA1C</measure>
    <time_frame>During the procedure</time_frame>
    <description>Glycated haemoglobin A1C</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TIR</measure>
    <time_frame>During the procedure</time_frame>
    <description>Time in range (TIR, 3.9-10 mmol/L, 70-180 mg/dL) of the interstitial glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TAR</measure>
    <time_frame>During the procedure</time_frame>
    <description>Time above range (TAR, &gt;10 mmol/L, &gt;180 mg/dL) of the interstitial glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TUR</measure>
    <time_frame>During the procedure</time_frame>
    <description>Time under range (TUR, &lt;3.9 mmol/L, &lt;70 mg/dL) of the interstitial glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical significant hypoglycemia</measure>
    <time_frame>During the procedure</time_frame>
    <description>Time in clinical significant hypoglycemia (&lt; 3 mmol/L, &lt;54 mg/dL) of the interstitial glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MIG</measure>
    <time_frame>During the procedure</time_frame>
    <description>Mean interstitial glucose (mmol/L, mg/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>%CV</measure>
    <time_frame>During the procedure</time_frame>
    <description>Percentage of the variation coefficient (%, &gt;36% is considered high levels)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to CGM</measure>
    <time_frame>During the procedure</time_frame>
    <description>Time of use of continuous glucose monitoring (% possible time of use)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>During the procedure</time_frame>
    <description>Total corporal weight (Kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin dose</measure>
    <time_frame>During the procedure</time_frame>
    <description>Daily insulin dose requirements (UI/Kg/d)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DKA</measure>
    <time_frame>During the procedure</time_frame>
    <description>Number of diabetic ketoacidosis (number of events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe hypoglycemia</measure>
    <time_frame>During the procedure</time_frame>
    <description>Number of severe hypoglycemia (number of events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital admission</measure>
    <time_frame>During the procedure</time_frame>
    <description>Number of hospital admission due to insulin pump (number of events)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">154</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Insulin pump</arm_group_label>
    <description>All patient treated with insulin pump.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Insulin pump</intervention_name>
    <description>Treatment with continuous subcutaneous insulin infusion</description>
    <arm_group_label>Insulin pump</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All type 1 diabetes patients treated with continuous subcutaneous insulin infusion in&#xD;
        Spain.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 1 diabetes patients treated with insulin pump.&#xD;
&#xD;
          -  Medical treatment received in Spain.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Any other kinds of diabetes.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitario Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eva Aguilera, MD</last_name>
      <phone>934 65 12 00</phone>
      <email>aguilerahurtado@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital San Joan de Deu</name>
      <address>
        <city>Esplugues De Llobregat</city>
        <state>Barcelona</state>
        <zip>08950</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmen Yoldi, RN</last_name>
      <phone>93 253 21 00</phone>
      <email>cyoldi@sjdhospitalbarcelona.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Mutua de Tarrasa</name>
      <address>
        <city>Terrassa</city>
        <state>Barcelona</state>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuria Alonso, MD</last_name>
      <phone>937 36 50 50</phone>
      <email>yusalonso@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Carmen Quiros, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Jerez</name>
      <address>
        <city>Jerez De La Frontera</city>
        <state>Cadiz</state>
        <zip>11407</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosa Marquez, RN</last_name>
      <phone>956 03 20 00</phone>
      <email>rosa_marquez_pardo@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago De Compostela</city>
        <state>La Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcos Pazos, PhD</last_name>
      <phone>981 95 00 00</phone>
      <email>marcos.pazos@usc.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Infanta Sofía</name>
      <address>
        <city>San Sebastián De Los Reyes</city>
        <state>Madrid</state>
        <zip>28703</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharona Azriel, PhD</last_name>
      <phone>911 91 40 00</phone>
      <email>sharona.azriel@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Carlos Haya</name>
      <address>
        <city>Málaga</city>
        <state>Malaga</state>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marta Dominguez, MD</last_name>
      <phone>951 29 00 00</phone>
      <email>mmelilla@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Maria Sol Ruiz, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <state>Malaga</state>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diego Fernandez, PhD</last_name>
      <phone>951 03 20 00</phone>
      <email>diegofernandezgarcia@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria Jose Picon, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Jose Goñi, MD</last_name>
      <phone>848 42 22 22</phone>
      <email>mariajosegoniiriarte@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Badajoz University Hospital</name>
      <address>
        <city>Badajoz</city>
        <zip>06080</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar Beato Vibora, PhD, MD</last_name>
      <phone>924218100</phone>
      <email>p.beatovibora@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic i Provincial</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margarita Gimenez, PhD</last_name>
      <phone>932 27 54 00</phone>
      <email>gimenez@clinic.cat</email>
    </contact>
    <investigator>
      <last_name>Merce Vidal, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana Chico, PhD</last_name>
      <phone>932 91 90 00</phone>
      <email>achicob@santpau.cat</email>
    </contact>
    <investigator>
      <last_name>Cintia Gonzalez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Basurto</name>
      <address>
        <city>Bilbao</city>
        <zip>48013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Estivaliz Ugarte, MD</last_name>
      <phone>944 00 60 00</phone>
      <email>estiug@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Obispo Rafael Torija, St.</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jesus Moreno-Fernandez, MD, PhD</last_name>
      <phone>926278000</phone>
      <phone_ext>79509</phone_ext>
      <email>jmorenof@sescam.jccm.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Medico D-Medical</name>
      <address>
        <city>Madrid</city>
        <zip>28001</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raquel Barrios, PhD</last_name>
      <phone>914 36 26 36</phone>
      <email>rbarriocastellanos@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Pilar Martin, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor M Andia, MD</last_name>
      <phone>915 86 80 00</phone>
      <email>victorandiam@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Beatriz Garcia, MD</last_name>
      <phone>913 36 80 00</phone>
      <email>bgcuartero@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Maria Belen Roldan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Cuesta, MD</last_name>
      <phone>913 30 30 00</phone>
      <email>cuestamartintutor@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mercedes Galindo, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica DiaLibre</name>
      <address>
        <city>Madrid</city>
        <zip>28702</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Graciela Lou, MD</last_name>
      <phone>910 34 06 63</phone>
      <email>gracielaloufrances@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Virgina Bellido, MD</last_name>
      <phone>955 01 20 00</phone>
      <email>virginiabellido@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gema Lopez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Asuncion Martinez, PhD</last_name>
      <phone>955 01 20 00</phone>
      <email>mmbrocca@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Joan XXIII</name>
      <address>
        <city>Tarragona</city>
        <zip>43005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inmaculada Simon, RN</last_name>
      <phone>977 29 58 00</phone>
      <email>isimon.hj23.ics@gencat.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francisco J Ampudia, PhD</last_name>
      <phone>961 97 35 00</phone>
      <email>ampudia_fra@gva.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Teresa Penalva, MD</last_name>
      <phone>961 24 40 00</phone>
      <email>penalbamaite@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pilar Bahillo, RN</last_name>
      <phone>983 42 00 00</phone>
      <email>pilarbahilloc@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Gonzalo Diaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986 May 22;314(21):1360-8. Review.</citation>
    <PMID>3517648</PMID>
  </reference>
  <reference>
    <citation>Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr. 1994 Aug;125(2):177-88.</citation>
    <PMID>8040759</PMID>
  </reference>
  <reference>
    <citation>Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.</citation>
    <PMID>22777524</PMID>
  </reference>
  <reference>
    <citation>Sastre J, Pinés PJ, Moreno J, Aguirre M, Blanco B, Calderón D, Herranz S, Roa C, Lopez J; Grupo de estudio DIACAM 1. Metabolic control and treatment patterns in patients with type 1 diabetes in Castilla-La Mancha: the DIAbetes tipo 1 in Castilla La Mancha study. Endocrinol Nutr. 2012 Nov;59(9):539-46. doi: 10.1016/j.endonu.2012.07.003. Epub 2012 Oct 4. English, Spanish.</citation>
    <PMID>23039989</PMID>
  </reference>
  <reference>
    <citation>Beato-Víbora P, Chico-Ballesteros A, Giménez M, Guerrero-Vázquez R, Barrio-Castellanos R, Goñi-Iriarte MJ, Díaz-Soto G, Merino-Torres JF, Moreno-Fernández J, Martínez-Brocca MA; Diabetes Technology Working Group of the Spanish Diabetes Association. A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain. Diabetes Res Clin Pract. 2018 Mar;137:56-63. doi: 10.1016/j.diabres.2017.12.009. Epub 2017 Dec 24.</citation>
    <PMID>29278712</PMID>
  </reference>
  <reference>
    <citation>Moreno-Fernandez J, Gomez FJ, Pinés P, González J, López J, López LM, Blanco B, Roa C, Herranz S, Muñoz-Rodríguez JR. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System. Diabetes Technol Ther. 2019 Aug;21(8):440-447. doi: 10.1089/dia.2019.0097. Epub 2019 Jun 13.</citation>
    <PMID>31199682</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Castilla-La Mancha Health Service</investigator_affiliation>
    <investigator_full_name>Jesús Moreno Fernández</investigator_full_name>
    <investigator_title>Endocrinologist</investigator_title>
  </responsible_party>
  <keyword>Type 1 diabetes</keyword>
  <keyword>Treatment</keyword>
  <keyword>Insulin pump</keyword>
  <keyword>Continuous subcutaneous insulin infusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD will be available after studying each request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

